Discrepancies Between the Cost of Advanced Lung Cancer Treatment and How Much Is Reimbursed by the Brazilian Public Healthcare System-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discrepancies Between the Cost of Advanced Lung Cancer Treatment and How Much Is Reimbursed by the Brazilian Public Healthcare System

Published:2023-01 Issue: Volume:33 Page:1-6
ISSN:2212-1099
Container-title:Value in Health Regional Issues
language:en
Short-container-title:Value in Health Regional Issues

Author:

Kelner Marina,Carvalho da Silva Bruna,Montella Tatiane,Aguiar Pedro Nazareth,Lopes Gilberto,Ferreira Carlos G.,De Marchi Pedro

Funder

Boehringer Ingelheim

Pfizer

AstraZeneca

Amgen

Bristol-Myers Squibb

Meso Scale Diagnostics

Publisher

Elsevier BV

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Reference36 articles.

1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;Ferlay;Int J Cancer,2019

2. Atlas On-line de Mortalidade. INCA - Instituto Nacional do Câncer. https://www.inca.gov.br/MortalidadeWeb/pages/Modelo01/consultar.xhtml;jsessionid=34481167EBA07D63B9A790DF95AA111C#panelResultado. Accessed September 20, 2022.

3. The emerging treatment landscape of targeted therapy in non-small-cell lung cancer;Yuan;Signal Transduct Target Ther,2019

4. Registrational dataset from the phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET fusion+ non-small cell lung cancer (NSCLC);Gainor;J Clin Oncol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP